Literature DB >> 15356064

Evidence of early ovarian aging in fragile X premutation carriers.

C K Welt1, P C Smith, A E Taylor.   

Abstract

Up to 28% of female fragile X premutation carriers develop premature ovarian failure. To test the hypothesis that fragile X premutation carriers with ovulatory menstrual cycles exhibit hormone changes characteristic of early ovarian aging, 11 regularly cycling fragile X premutation carriers, 24-41 yr old (34.5 +/- 5.7 yr, mean +/- sd), drew daily blood samples across one menstrual cycle. LH, FSH, estradiol, progesterone (P4), inhibin A, and inhibin B levels were compared with levels in 22 age-matched, regularly cycling women, 23-41 yr old (34.6 +/- 5.8 yr), at each cycle stage. Total cycle (26.1 +/- 1.0 vs. 28.2 +/- 0.4 d; P < 0.05) and follicular phase length (12.9 +/- 0.8 vs. 14.5 +/- 0.4 d; P < 0.05) were decreased in fragile X premutation carriers compared with age-matched controls, whereas luteal phase length was similar (13.2 +/- 0.5 vs. 13.7 +/- 0.3 d; P = not significant). FSH was elevated across the follicular (21.9 +/- 3.5 vs. 11.2 +/- 0.5 IU/liter; P < 0.001) and luteal phases (14.6 +/- 3.9 vs. 7.9 +/- 0.5 IU/liter; P < 0.05) in fragile X premutation carriers compared with age-matched controls. Inhibin B in the follicular phase (77 +/- 11 vs. 104 +/- 6 pg/ml; P < 0.05) and inhibin A (3.4 +/- 0.7 vs. 5.8 +/- 0.5 IU/ml; P < 0.01) and P4 [7.3 +/- 1.0 vs. 10.1 +/- 0.7 ng/ml (23.2 +/- 3.0 vs. 32.1 +/- 2.3 nmol/liter); P < 0.05] in the luteal phase were decreased in fragile X premutation carriers compared with age-matched controls, whereas there was no difference in estradiol or LH. In summary, despite regular ovulatory cycles, FSH was increased in fragile X premutation carriers compared with age-matched controls. The increased FSH was accompanied by decreased inhibin B in the follicular phase and inhibin A and P4 in the luteal phase. These hormonal changes suggest that fragile X premutation carriers exhibit early ovarian aging despite regular menstrual cycles. Early ovarian aging in fragile X premutation carriers likely results from decreased follicle number and function, as reflected by lower inhibin B, inhibin A, and P4 levels.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15356064     DOI: 10.1210/jc.2004-0347

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  51 in total

Review 1.  Ovarian aging and premature ovarian failure.

Authors:  Yavuz Emre Sükür; Içten Balık Kıvançlı; Batuhan Ozmen
Journal:  J Turk Ger Gynecol Assoc       Date:  2014-08-08

2.  Ovarian histopathological and ubiquitin-immunophenotypic features in fragile X-associated primary ovarian insufficiency: a study of five cases and selected controls.

Authors:  Martin C Chang; John J DeCaro; Mei Zheng; Marla Gearing; Lisa Shubeck; Stephanie L Sherman; Corrine K Welt
Journal:  Histopathology       Date:  2011-10-18       Impact factor: 5.087

3.  Molecular Characterization of FMR1 Gene by TP-PCR in Women of Reproductive Age and Women with Premature Ovarian Insufficiency.

Authors:  Deepika Delsa Dean; Sarita Agarwal; Deepa Kapoor; Kuldeep Singh; Chandra Vati
Journal:  Mol Diagn Ther       Date:  2018-02       Impact factor: 4.074

4.  Improving Health Education for Women Who Carry an FMR1 Premutation.

Authors:  Whitney Espinel; Krista Charen; Lillie Huddleston; Jeannie Visootsak; Stephanie Sherman
Journal:  J Genet Couns       Date:  2015-07-16       Impact factor: 2.537

Review 5.  FMR1: a gene with three faces.

Authors:  Ben A Oostra; Rob Willemsen
Journal:  Biochim Biophys Acta       Date:  2009-02-21

Review 6.  Developmental Programming of Ovarian Functions and Dysfunctions.

Authors:  Muraly Puttabyatappa; Vasantha Padmanabhan
Journal:  Vitam Horm       Date:  2018-02-22       Impact factor: 3.421

7.  Does the presence of AGG interruptions within the CGG repeat tract have a protective effect on the fertility phenotype of female FMR1 premutation carriers?

Authors:  M Friedman-Gohas; M Kirshenbaum; A Michaeli; N Domniz; S Elizur; H Raanani; R Orvieto; Y Cohen
Journal:  J Assist Reprod Genet       Date:  2020-02-24       Impact factor: 3.412

8.  Expanded clinical phenotype of women with the FMR1 premutation.

Authors:  Sarah M Coffey; Kylee Cook; Nicole Tartaglia; Flora Tassone; Danh V Nguyen; Ruiqin Pan; Hannah E Bronsky; Jennifer Yuhas; Mariya Borodyanskaya; Jim Grigsby; Melanie Doerflinger; Paul J Hagerman; Randi J Hagerman
Journal:  Am J Med Genet A       Date:  2008-04-15       Impact factor: 2.802

9.  X-chromosome terminal deletion in a female with premature ovarian failure: Haploinsufficiency of X-linked genes as a possible explanation.

Authors:  Susana I Ferreira; Eunice Matoso; Marta Pinto; Joana Almeida; Thomas Liehr; Joana B Melo; Isabel M Carreira
Journal:  Mol Cytogenet       Date:  2010-07-20       Impact factor: 2.009

10.  Top-down or bottom-up: Contrasting perspectives on psychiatric diagnoses.

Authors:  Willem Ma Verhoeven; Siegfried Tuinier; Ineke van der Burgt
Journal:  Biologics       Date:  2008-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.